ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

CIS Celebrates 15th Anniversary, Praised By M. Quayle

December 6, 1991

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

RFA On Hepatitis B Virus, Liver Cancer

April 15, 1983

New Cooperative Group Funded

September 30, 1977